ReShape Lifesciences Inc (NASDAQ:RSLS) price closed lower on Tuesday, April 08, and dropping -12.53% below its previous close.
A look at the daily price movement shows that the last close reads $0.43, with intraday deals fluctuated between $0.379 and $0.4796. Taking into account the 52-week price action we note that the stock hit a 52-week high of $29.00 and 52-week low of $0.34. The stock subtracted -48.41% on its value in the past month.
ReShape Lifesciences Inc, which has a market valuation of $4.28 million, is expected to release its quarterly earnings report on 2024-Nov-13.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give RSLS a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned RSLS a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the ReShape Lifesciences Inc (RSLS) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that RSLS’s price is at present -35.34% off the SMA20 and -74.13% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 40.29, with weekly volatility standing at 51.35%. The indicator jumps to 36.44% when calculated based on the past 30 days. ReShape Lifesciences Inc (NASDAQ:RSLS)’s beta value is holding at 1.14, while the average true range (ATR) indicator is currently reading 0.33.
An analysis of the ReShape Lifesciences Inc (NASDAQ:RSLS) stock in terms of its daily trading volume indicates that the 3-month average is 9.10 million. However, this figure increases on the past 10-day timeline to an average of 48.95 million.
Current records show that the company has 3.31M in outstanding shares. The insiders’ percentage holdings are 18.08% of outstanding shares while the percentage share held by institutions stands at 1.01%. The stats also highlight that short interest as of 2025-03-14, stood at 0.37 million shares, which puts the short ratio at the time at 0.11. From this we can glean that short interest is 1111.00 of company’s current outstanding shares. Notably, we see that shares short in March rose slightly given the previous month’s figure stood at 82814.0. But the -91.50% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
